Myriad Genetics Inc (FRA:MYD)
€ 13 -0.1 (-0.76%) Market Cap: 1.21 Bil Enterprise Value: 1.25 Bil PE Ratio: 0 PB Ratio: 1.70 GF Score: 72/100

Q4 2022 Myriad Genetics Inc Earnings Call Transcript

Feb 28, 2023 / 09:30PM GMT
Operator

Greetings, and welcome to the Myriad Genetics Fourth Quarter 2022 Financial Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded Tuesday, February 28, 2023. I'd now like to turn the call over to Matt Scalo. Please go ahead.

Matthew Scalo
Myriad Genetics, Inc. - SVP of IR

Okay. Good afternoon, and welcome to the Myriad Genetics Fourth Quarter and Full Year 2022 Earnings Call.

During the call, we will review financial results we released today and afterwards, we will host a Q&A session.

Our quarterly earnings release was issued this afternoon on Form 8-K and can be found on our website at investor.myriad.com.

I'm Matt Scalo, Senior Vice President of Investor Relations, and on the call with me today are Paul Diaz, our President and Chief Executive Officer; Bryan Riggsbee, our Chief Financial Officer; Nicole Lambert, our Chief Operating Officer; and Mark Verratti, our Chief Commercial Officer.

This call can be heard live via webcast at investor.myriad.com, and a recording will be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot